Pieris Pharmaceuticals, Inc.
(NASDAQ CM: PIRS)
Rigrodsky Law, P.A. is investigating Pieris Pharmaceuticals, Inc. (“Pieris”) regarding possible breaches of fiduciary duties and other violations of law related to Pieris’s agreement to merge with Palvella Therapeutics, Inc.